{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:31:14Z","timestamp":1792225874141,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.mjafi.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T21:35:24Z","timestamp":1694554524000},"page":"621-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hematopoietic cell transplantation landscape in India"],"prefix":"10.1016","volume":"79","author":[{"given":"Velu","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Yanamandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Nazneen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.mjafi.2023.09.002_bib1","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1038\/bmt.2008.124","article-title":"Stem cell transplantation in India","volume":"42","author":"Chandy","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.mjafi.2023.09.002_bib2","series-title":"Hematopoietic Stem Cell Transplantation. API Textbook of Medicine","first-page":"1365","author":"Nair","year":"2015"},{"key":"10.1016\/j.mjafi.2023.09.002_bib3","series-title":"National guideline for hematopoietic cell transplantation","year":"2021"},{"key":"10.1016\/j.mjafi.2023.09.002_bib4","series-title":"Evidence Based Status of Stem Cell Therapy for Human Diseases","year":"2021"},{"issue":"10","key":"10.1016\/j.mjafi.2023.09.002_bib5","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41409-019-0516-2","article-title":"Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019","volume":"54","author":"Duarte","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.mjafi.2023.09.002_bib6","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbmt.2019.05.002","article-title":"Worldwide network for blood and marrow transplantation recommendations for establishing a hematopoietic cell transplantation program, Part I: minimum requirements and beyond","volume":"25","author":"Pasquini","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.mjafi.2023.09.002_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-116-3-263","article-title":"Valuing clinical strategies early in their development","volume":"116","author":"Welch","year":"1992","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.mjafi.2023.09.002_bib8","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.bbmt.2019.04.012","article-title":"Worldwide network for blood and marrow transplantation recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources, Part II: clinical, technical, and socioeconomic considerations","volume":"25","author":"Aljurf","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.mjafi.2023.09.002_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bmt.1705733","article-title":"Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy","volume":"40","author":"Saito","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.mjafi.2023.09.002_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/bmt.2010.10","article-title":"The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation","volume":"45","author":"Petersdorf","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.mjafi.2023.09.002_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JGO.2016.006650","article-title":"Allogeneic stem cell transplant for acute myeloid leukemia: evolution of an effective strategy in India","volume":"3","author":"Ganapule","year":"2017","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.mjafi.2023.09.002_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12288-018-0989-y","article-title":"Clinical outcomes in multiple myeloma post-autologous transplantation\u2014a single centre experience","volume":"35","author":"Kulkarni","year":"2019","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"6","key":"10.1016\/j.mjafi.2023.09.002_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4103\/ijmr.IJMR_1593_18","article-title":"High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: predictors of long-term outcome","volume":"149","author":"Kumar","year":"2019","journal-title":"Indian J Med Res"},{"issue":"6","key":"10.1016\/j.mjafi.2023.09.002_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.mjafi.2023.09.005","article-title":"Bone marrow transplant: A two-decade single centre hematology experience","volume":"79","author":"Kumar","year":"2023","journal-title":"Med J Armed Forces India"},{"issue":"1","key":"10.1016\/j.mjafi.2023.09.002_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0041-1731599","article-title":"Hematopoietic Stem Cell Transplant for Hematological Malignancies: Experience from a Tertiary Care Center in Northern India and Review of Indian Data","volume":"11","author":"Sharma","year":"2022","journal-title":"South Asian J Cancer"},{"issue":"4","key":"10.1016\/j.mjafi.2023.09.002_bib16","first-page":"53","article-title":"Allogeneic haematopoietic stem cell transplantation: Army hospital experience","volume":"47","author":"Nair","year":"2011","journal-title":"Ann Natl Acad Med Sci"},{"key":"10.1016\/j.mjafi.2023.09.002_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606930","article-title":"Multicenter outcome of hematopoietic stem cell transplantation for primary immune deficiency disorders in India","volume":"11","author":"Raj","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.mjafi.2023.09.002_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12288-020-01254-3","article-title":"Hematopoietic stem cell transplantation for fanconi anemia: a single center experience from India","volume":"36","author":"Doval","year":"2020","journal-title":"Indian J Hematol Blood Trans"},{"issue":"3","key":"10.1016\/j.mjafi.2023.09.002_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12288-020-01374-w","article-title":"Haploidentical hematopoietic stem cell transplantation in leukemia's: experience from a cancer center in India","volume":"37","author":"Batra","year":"2021","journal-title":"Indian J Hematol Blood Trans"},{"issue":"3","key":"10.1016\/j.mjafi.2023.09.002_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13918","article-title":"Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: lessons learnt from a tertiary care center in India","volume":"25","author":"Arora","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.mjafi.2023.09.002_bib21","first-page":"241","article-title":"Hematopoietic stem cell transplantation in children with genetic defects","volume":"46","author":"Nair","year":"2009","journal-title":"Indian Pediatr"},{"issue":"2","key":"10.1016\/j.mjafi.2023.09.002_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0377-1237(05)80025-5","article-title":"The first allogeneic bone marrow transplantation in the armed forces for thalassemia","volume":"61","author":"Nair","year":"2005","journal-title":"Med J Armed Forces India"},{"issue":"3","key":"10.1016\/j.mjafi.2023.09.002_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/ijmpo.ijmpo_159_20","article-title":"Blood and bone marrow transplantation in India: past, present, and future","volume":"41","author":"Saikia","year":"2020","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"14","key":"10.1016\/j.mjafi.2023.09.002_bib24","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2017-08-798322","article-title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"G\u00f6kbuget","year":"2018","journal-title":"Blood"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123723001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123723001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:47:36Z","timestamp":1762303656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123723001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0377123723001557"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2023.09.002","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic cell transplantation landscape in India","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}